EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 22016D2189
Decision of the EEA Joint Committee No 154/2015 of 11 June 2015 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2016/2189]
Decision of the EEA Joint Committee No 154/2015 of 11 June 2015 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2016/2189]
Decision of the EEA Joint Committee No 154/2015 of 11 June 2015 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2016/2189]
OJ L 341, 15.12.2016, p. 48–49
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
Relation | Act | Comment | Subdivision concerned | From | To |
---|---|---|---|---|---|
Modifies | 21994A0103(52) | Addition | chapter XV point 13a indent | 12/06/2015 | |
Modifies | 21994A0103(52) | Addition | chapter XV point 13zzzzp | 12/06/2015 |
15.12.2016 |
EN |
Official Journal of the European Union |
L 341/48 |
DECISION OF THE EEA JOINT COMMITTEE
No 154/2015
of 11 June 2015
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2016/2189]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
(1) |
Commission Implementing Regulation (EU) 2015/306 of 26 February 2015 renewing the approval of the active substance Isaria fumosorosea strain Apopka 97 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement. |
(2) |
Commission Implementing Regulation (EU) 2015/307 of 26 February 2015 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance triclopyr (2) is to be incorporated into the EEA Agreement. |
(3) |
Commission Implementing Regulation (EU) 2015/308 of 26 February 2015 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance Z,Z,Z,Z-7,13,16,19-docosatetraen-1-yl isobutyrate (3) is to be incorporated into the EEA Agreement. |
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
(1) |
the following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
|
(2) |
the following point is inserted after point 13zzzzl (Commission Implementing Regulation (EU) 2015/51):
|
Article 2
The texts of Implementing Regulations (EU) 2015/306, (EU) 2015/307 and (EU) 2015/308 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 12 June 2015, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 11 June 2015.
For the EEA Joint Committee
The President
Gianluca GRIPPA
(*1) No constitutional requirements indicated.